anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Callout

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 96,741
Current window 75,961-75,990
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all
18 30 60

Component

75,961-75,990 of 96,741

filter-aware
260
The slide uses a Q&A format to build a case against the company's business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
261
The slide uses a Q&A format to highlight potential malpractice and coercion.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
262
The slide presents a narrative of a specific medical failure involving a necrotic liver, alleging that TransMedics may be concealing damage from receiving centers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
264
The slide uses a Q&A format to highlight a perceived cover-up by the company regarding device performance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
265
The slide uses a quote to highlight a perceived lack of transparency by the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
267
The slide uses a combination of summary text and direct interview transcripts to build a case of corporate misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
269
This appears to be a narrative slide from a research note or report, focusing on churn.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
270
The slide uses anecdotal evidence from a 'prominent surgeon' to support a bearish thesis on TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
271
The slide uses direct quotes from surgeons to build a narrative of financial unviability and institutional pushback against the product.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
272
The slide uses a Q&A format to directly contradict claims made by the TransMedics CEO regarding reimbursement pass-through.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
273
The slide uses direct quotes to build a narrative of customer churn and institutional resistance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
274
The slide uses Q&A transcripts to highlight a shift away from OCS technology in high-volume transplant centers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
275
The slide uses a 'villain critique' style to highlight negative sentiment from industry insiders regarding TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
276
The slide uses a Q&A format to highlight a specific expert's negative sentiment toward TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
277
The slide uses direct quotes from a high-volume TransMedics user to illustrate market vulnerability and the shift toward competitors offering more autonomy.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
278
The slide uses a Q&A format to build a narrative of market abandonment.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
279
The slide uses direct quotes from an UCSF administrator to build a case against TransMedics' long-term viability at the institution.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
280
The slide uses highlighted text to emphasize key negative sentiment regarding TransMedics' sustainability and market position.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
281
This slide serves as a highly critical, accusatory statement against the subject company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
282
The slide uses a testimonial from a transplant surgeon to support a bearish thesis on the company's market position.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
284
The slide uses direct quotes from a KOL to undermine the company's market position.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
285
The slide uses a 'villain critique' approach by aggregating expert opinions to undermine the company's value proposition.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
286
The slide uses a Q&A format to highlight the gap between the device's intended utility and real-world clinical experience.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
288
The slide uses a 'before-after' style comparison between a conceptual timeline and actual competitor hardware.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
289
The slide uses expert quotes to undermine the competitive moat of TransMedics by comparing it to existing, commoditized kidney perfusion technology.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
292
The slide uses highlighted text to emphasize key negative claims from a surgeon.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
295
The slide uses a direct quote from a surgeon to undermine the credibility and clinical utility of the TransMedics OCS device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
296
The slide uses a direct quote from an expert to undermine the value proposition of the TransMedics device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
297
The slide uses a quote-heavy structure to undermine the investment thesis for TransMedics (TMDX).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
298
The slide uses a Q&A transcript format to highlight negative expert sentiment.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit